繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Sonoma Pharmaceuticals to Effect 1-for-20 Reverse Stock Split

2024-08-28 19:21

07:21 AM EDT, 08/28/2024 (MT Newswires) -- Sonoma Pharmaceuticals (SNOA) said Wednesday it will effect a 1-for-20 reverse split of its common shares this Thursday.

Trading on an adjusted basis will begin Friday on the Nasdaq Capital Market, the company said.

The reverse stock split is intended to increase the per-share trading price of the company to satisfy Nasdaq's $1 minimum bid price requirement for continued listing.

Price: 0.1906, Change: -0.03, Percent Change: -12.13

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。